A phase I QTc study of tivozanib in patients with advanced solid tumors.

被引：0
|
作者：
Chadha, Manpreet Kaur
Infante, Jeffrey R.
Cotreau, Monette M.
Jacobson, Lindsey
Strahs, Andrew Louis
Slichenmyer, William
Vargo, Dennis
Moore, Kathleen N.
机构：
[1] Virginia G Piper Canc Ctr, Scottsdale, AZ USA
[2] TGen, Scottsdale, AZ USA
[3] Sarah Cannon Canc Ctr, Nashville, TN USA
[4] AVEO Pharmaceut, Cambridge, MA USA
[5] Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I study of aflibercept, pemetrexed (P), and cisplatin (C) in patients with advanced solid tumors.
    Townsley, C. A.
    Siu, L. L.
    Pedro-Salcedo, M. San
    Liu, L.
    Wakelee, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Phase I clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumors.
    Alexandre, J
    Tchen, N
    Berthault-Cvitkovic, F
    Misset, JL
    Benettaib, B
    Kahatt, C
    Raymond, E
    Weems, G
    MacDonald, JR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9057S - 9057S
  • [23] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [24] Results of phase I clinical trials of Coramsine in patients with advanced solid tumors.
    Millward, M.
    Powell, A.
    Daly, P.
    Tyson, S.
    Ferguson, R.
    Carter, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [25] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [26] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [27] A phase 1 study of oral navelbine in patients with advanced solid tumors.
    Rajdev, L
    Dai, Q
    Mani, S
    Goldberg, G
    Baker, C
    Hoschander, S
    Sparano, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6137S - 6137S
  • [28] A QTc study of cabazitaxel in patients with advanced solid tumors
    Wade, James Lloyd
    Dakhil, Shaker R.
    Baron, Ari David
    Rottey, Sylvie
    Millard, Frederick E.
    Daugaard, Gedske
    Machiels, Jean-Pascal H.
    Conkright, William A.
    Sharma, Sunil
    Soetekouw, Patricia M. M. B.
    Yachnin, Jeffrey
    Sengelov, Lisa
    van Veldhuizen, Peter
    Agarwala, Sanjiv S.
    Nguyen, T. X. Quyen
    Chadjaa, Mustapha
    Maison-Blanche, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [29] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [30] A phase I study of ARQ 197 in combination with temsirolimus in advanced solid tumors.
    Kyriakopoulos, Christos
    Kolesar, Jill
    Eickhoff, Jens C.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari Braun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345